Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens

OBJECTIVE: Adjuvant chemotherapy was introduced in patients with early-stage ovarian cancer (OC). The benefit of standard chemotherapeutic regimens including taxane has not been established. METHODS: Patients with early-stage OC from the National Health Insurance Research database of Taiwan who rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chien-An, Chiang, Chun-Ju, Chen, Yun-Yuan, You, San-Lin, Hsieh, Shu-Feng, Tang, Chao-Hsiun, Cheng, Wen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709526/
https://www.ncbi.nlm.nih.gov/pubmed/29185274
http://dx.doi.org/10.3802/jgo.2018.29.e16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709526/
https://www.ncbi.nlm.nih.gov/pubmed/29185274
http://dx.doi.org/10.3802/jgo.2018.29.e16

Ejemplares similares